Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Yasuyuki Shigematsu"'
Autor:
Emiko Sugawara, Yasuyuki Shigematsu, Gulanbar Amori, Keisuke Sugita, Junji Yonese, Kengo Takeuchi, Kentaro Inamura
Publikováno v:
Diagnostics, Vol 13, Iss 14, p 2408 (2023)
Female urethral adenocarcinoma has attracted attention as a rare tumor type based on its differential pathogenesis from its male counterpart. However, to date, our knowledge concerning its immunohistochemical and morphological characteristics remains
Externí odkaz:
https://doaj.org/article/c57005ff46da4f54a57d1a90e0a0e60f
Autor:
Yasuyuki Shigematsu, Kentaro Inamura, Noriko Yamamoto, Yoshihiro Mise, Akio Saiura, Yuichi Ishikawa, Shunji Takahashi, Hiroaki Kanda
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background The prognostic biomarker for patients undergoing curative liver metastasectomy for colorectal cancer (CRC) is lacking. The purpose was to investigate the prognostic role of a lack of CDX2 expression, which has been proposed as a p
Externí odkaz:
https://doaj.org/article/61ccdb00847643e38a607d2fe113b61c
Publikováno v:
Journal of Thoracic Oncology. 17:1318-1322
Autor:
Hiroki Murai, Takahiro Kodama, Kazuki Maesaka, Shoichiro Tange, Daisuke Motooka, Yutaka Suzuki, Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, Akio Saiura, Yoshihiro Ono, Yu Takahashi, Yota Kawasaki, Satoshi Iino, Shogo Kobayashi, Masashi Idogawa, Takashi Tokino, Tomomi Hashidate‐Yoshida, Hideo Shindou, Masanori Miyazaki, Yasuharu Imai, Satoshi Tanaka, Eiji Mita, Kazuyoshi Ohkawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Hidetoshi Eguchi, Eiichi Morii, Tetsuo Takehara
Publikováno v:
Hepatology. 77:77-91
Immunotherapy has become the standard-of-care treatment for hepatocellular carcinoma (HCC), but its efficacy remains limited. To identify immunotherapy-susceptible HCC, we profiled the molecular abnormalities and tumor immune microenvironment (TIME)
Autor:
Yasuyuki Shigematsu, Kentaro Inamura
Publikováno v:
JAMA Surgery.
Autor:
Yuta, Ushida, Takafumi, Sato, Tomotaka, Kato, Yasuyuki, Shigematsu, Hiromichi, Ito, Takeshi, Suzuki, Yosuke, Inoue, Yoshihiro, Ono, Atsushi, Oba, Yu, Takahashi
Publikováno v:
Clinical Journal of Gastroenterology. 15:427-432
A 67-year-old man presented with hemorrhagic shock due to the rupture of hepatic tumor and underwent emergency partial resection of the right liver. Pathological examination revealed hepatic angiosarcoma with involvement in its surgical margin. Six m
Autor:
Kentaro Inamura, Yasuyuki Shigematsu
Publikováno v:
Journal of Thoracic Disease.
Autor:
Yasuyuki Shigematsu, Kentaro Inamura
Publikováno v:
JAMA Oncology. 9:725
Autor:
Kentaro Inamura, Takeshi Yuasa, Kengo Takeuchi, Emiko Sugawara, Masashi Akiya, Gulanbar Amori, Shinya Yamamoto, Junji Yonese, Yasuyuki Shigematsu, Junko Kunieda
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:767-774
Prostate cancer spans a broad spectrum from indolent to deadly disease. In the management of prostate cancer, diagnostic biopsy specimens are important sources of data that inform the selection of treatment. B7-H3 (CD276), an immune checkpoint molecu
Autor:
Takeshi Yuasa, Tetsuya Urasaki, Naoki Fukuda, Noboru Numao, Junji Yonese, Mayu Yunokawa, Akihiro Ohmoto, Xiaofei Wang, Shunji Takahashi, Yasuyoshi Sato, Junichi Tomomatsu, Yasuyuki Shigematsu, Kentaro Inamura, Makiko Ono, Kenji Nakano, Naomi Hayashi, Yoshinobu Komai
Publikováno v:
Endocrine Journal. 68:1383-1390
Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. While mitotane is the only agent approved for ACC, clinical data are scarce, especially in the Asian population. We reviewed 10 patients with ACC who received mitotane as a si